advertisement

Topcon

Tosi GM 12

Showing records 1 to 12 | Display all abstracts from Tosi GM

106512 Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy
Di Maggio A
European Journal of Ophthalmology 2022; 0: 11206721221143157
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Spini A; Giometto S
American Journal of Ophthalmology 2022; 248: 45-50
106512 Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy
Volpi N
European Journal of Ophthalmology 2022; 0: 11206721221143157
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Donnini S
American Journal of Ophthalmology 2022; 248: 45-50
106512 Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy
Marigliani D; Garosi G
European Journal of Ophthalmology 2022; 0: 11206721221143157
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Posarelli M
American Journal of Ophthalmology 2022; 248: 45-50
106512 Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy
Rollo F
European Journal of Ophthalmology 2022; 0: 11206721221143157
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Dotta F; Ziche M
American Journal of Ophthalmology 2022; 248: 45-50
106512 Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy
Ginanneschi F; Tosi GM
European Journal of Ophthalmology 2022; 0: 11206721221143157
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Tosi GM; Girardi A
American Journal of Ophthalmology 2022; 248: 45-50
106512 Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy
Fabiani C
European Journal of Ophthalmology 2022; 0: 11206721221143157
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Lucenteforte E; Gini R; Etminan M; Virgili G
American Journal of Ophthalmology 2022; 248: 45-50

Issue 23-3

Change Issue


advertisement

Oculus